Treace Medical Concepts (TMCI) - Net earnings per share (EPS TTM)
Net income per share over the last four quarters demonstrates capital management efficiency, where -0.86 shows the current value of the metric for Treace Medical Concepts (TMCI). Cash flow remains stable due to the implementation of foot correction systems. Patent protection of a narrow niche ensures high margins. However, expansion by large orthopedic behemoths creates risks of market share loss.
TMCI (Treace Medical): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization indicators:
- business book valuation details:
- debt and liquidity details:
Debt to Equity Treace Medical Concepts|TMCI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Treace Medical Concepts Inc|TMCI - Company Cumulative Debt|Debts to Book Capitalization Treace Medical Concepts|TMCI - Company Long-Term Indebtedness|Company Short-Term Debts Treace Medical Concepts|Quick Ratio treace.com
- net income and valuation multiples indicators:
TMCI - Net Income|Projected Future Earnings Treace Medical Concepts|TMCI - P/E Multiple|Future Price to Earnings Treace Medical|TMCI - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Treace Corp|TMCI - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Treace Medical Concepts|TMCI - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months treace.com|TMCI - Net earnings per share change in current year|Expected earnings per share growth for next year Treace Medical Concepts
- sales volume and revenue information:
Basic company analysis:Treace Medical (TMCI)
The aggressive scaling of Treace Medical Concepts (TMCI) through surgeon training and the capture of the foot correction market requires strict control over capital efficiency. By analyzing the rolling earnings per share trend, an investor assesses the final financial result adjusted for share dilution, which allows for the verification of the issuer's actual margin of safety and eliminates the risk of inflating business value through leverage.
Direct competitors
Boston Scientific Corporation Inc. - Net earnings per share (EPS TTM)|EW (Edwards Lifesciences Corp) - Earnings per share for the last 12 months|RMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months OmniPod (PODD)|Net earnings per share for the last 12 months ZBH|COO: Earnings per share for the trailing year|Net earnings per share for the last 12 months ALGN (Align Technology)|GMED (Globus Medical Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months TransMedics Group TMDX|ATEC - Net earnings per share for the last 12 months|CryoLife - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enovis Corporation|IART: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ESTA|BBNX (iLet Bionic Pancreas) - Net earnings per share (EPS TTM)|Iradimed (IRMD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EMBC|Net earnings per share for the last 12 months Tandem Diabetes Care TNDM|Net earnings per share (EPS TTM) AXGN (axogeninc.com)|Net earnings per share (EPS TTM) SI-BONE Inc SIBN|OFIX - Earnings per share for the last twelve months|Earnings per share for the trailing year BVS (Bioventus Corp)|KIDS (OrthoPediatrics Inc.) - Net earnings per share for the last 12 months|Strata Critical Medical Inc - Earnings per share for the trailing year|CARL (Carlsmed Medical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months RxSight Inc RXST|Earnings per share for the last twelve months ClearPoint Neuro (CLPT)|Stereotaxis, Inc. (STXS) - Net earnings per share for the trailing year|Neuronetics, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Sight Sciences, Inc. SGHT|Orchestra BioMed Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Anika Therapeutics, Inc. ANIK|InspireMD (NSPR) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZJYL (Jin Medical International Ltd)|Earnings per share for the last twelve months vivani.com|Net earnings per share for the last 12 months Xtant Medical Holdings (XTNT)|Net earnings per share (EPS TTM) NMTC|MODD - Net earnings per one share for the last twelve months|Myomo - Net earnings per share for the last 12 months|COCH: Earnings per share for the last 12 months|VVOS: Net earnings per share for the last 12 months|enVVeno Medical - Earnings per share for the last four quarters|Sintx Technologies (SINT) - Earnings per share for the last twelve months|TNON: Earnings per share for the last four quarters|LFWD (rewalk.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Autonomix Medical|Earnings per share for the last twelve months INVO Bioscience (IVF)|Bone Biologics - Earnings per share for the last 12 months|Earnings per share for the last twelve months Axonics Modulation Technologies AXNX|BIOLASE - Earnings per share for the last twelve months|DYNT: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Paragon 28|INVO: Net earnings per share (EPS TTM)
